Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 21 entries
Sorted by: Best Match Show Resources per page
[Infection prevention in Dutch hospitals; results say more than process indicators].

Nederlands tijdschrift voor geneeskunde

Bonten MJ, Friedrich A, Kluytmans JA, Vandenbroucke-Grauls CM, Voss A, Vos MC.
PMID: 24594133
Ned Tijdschr Geneeskd. 2014;158:A7395.

The Dutch Health Care Inspectorate investigated the preparedness of Dutch hospitals for the emergence of antibiotic resistance, and concluded that hospitals are not well prepared and are insufficiently aware that infection prevention is a prerequisite for patient safety. These...

Cite
Bonten MJ, Friedrich A, Kluytmans JA, et al. Infectiepreventie in Nederlandse ziekenhuizen; resultaten zeggen meer dan procesindicatoren. [Infection prevention in Dutch hospitals; results say more than process indicators]. Ned Tijdschr Geneeskd. 2014;158:A7395
Bonten, M. J., Friedrich, A., Kluytmans, J. A., Vandenbroucke-Grauls, C. M., Voss, A., & Vos, M. C. (2014). Infectiepreventie in Nederlandse ziekenhuizen; resultaten zeggen meer dan procesindicatoren. [Infection prevention in Dutch hospitals; results say more than process indicators]. Nederlands tijdschrift voor geneeskunde, 158A7395.
Bonten, Marc J M, et al. "Infectiepreventie in Nederlandse ziekenhuizen; resultaten zeggen meer dan procesindicatoren." [Infection prevention in Dutch hospitals; results say more than process indicators]. Nederlands tijdschrift voor geneeskunde vol. 158 (2014): A7395.
Bonten MJ, Friedrich A, Kluytmans JA, Vandenbroucke-Grauls CM, Voss A, Vos MC. Infectiepreventie in Nederlandse ziekenhuizen; resultaten zeggen meer dan procesindicatoren. [Infection prevention in Dutch hospitals; results say more than process indicators]. Ned Tijdschr Geneeskd. 2014;158:A7395. Dutch. PMID: 24594133.
Copy Download .nbib Format: NLM
External validation of two prediction tools for patients at risk for recurrent .

Therapeutic advances in gastroenterology

van Rossen TM, van Dijk LJ, Heymans MW, Dekkers OM, Vandenbroucke-Grauls CMJE, van Beurden YH.
PMID: 33456500
Therap Adv Gastroenterol. 2021 Jan 09;14:1756284820977385. doi: 10.1177/1756284820977385. eCollection 2021.

BACKGROUND: One in four patients with primary METHODS: The validation cohort consisted of 129 patients, diagnosed with CDI between 2018 and 2020. rCDI risk scores were calculated for each individual patient in the validation cohort using the scoring tools...

Cite
van Rossen TM, van Dijk LJ, Heymans MW, et al. External validation of two prediction tools for patients at risk for recurrent . Therap Adv Gastroenterol. 2021;14:1756284820977385doi: 10.1177/1756284820977385.
van Rossen, T. M., van Dijk, L. J., Heymans, M. W., Dekkers, O. M., Vandenbroucke-Grauls, C. M. J. E., & van Beurden, Y. H. (2021). External validation of two prediction tools for patients at risk for recurrent . Therapeutic advances in gastroenterology, 141756284820977385. https://doi.org/10.1177/1756284820977385
van Rossen, Tessel M, et al. "External validation of two prediction tools for patients at risk for recurrent ." Therapeutic advances in gastroenterology vol. 14 (2021): 1756284820977385. doi: https://doi.org/10.1177/1756284820977385
van Rossen TM, van Dijk LJ, Heymans MW, Dekkers OM, Vandenbroucke-Grauls CMJE, van Beurden YH. External validation of two prediction tools for patients at risk for recurrent . Therap Adv Gastroenterol. 2021 Jan 09;14:1756284820977385. doi: 10.1177/1756284820977385. eCollection 2021. PMID: 33456500; PMCID: PMC7797589.
Copy Download .nbib Format: NLM
Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study.

The Journal of antimicrobial chemotherapy

Willems RPJ, van Dijk K, Dierikx CM, Twisk JWR, van der Klis FRM, de Greeff SC, Vandenbroucke-Grauls CMJE.
PMID: 34550358
J Antimicrob Chemother. 2021 Sep 22; doi: 10.1093/jac/dkab345. Epub 2021 Sep 22.

BACKGROUND: Gastric acid-suppressive therapy has been suggested to increase the risk for intestinal carriage of MDR Enterobacterales, but there is scarce community-based evidence substantiating this risk.OBJECTIVES: To investigate if acid-suppressant use is associated with a risk of intestinal carriage...

Cite
Willems RPJ, van Dijk K, Dierikx CM, et al. Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study. J Antimicrob Chemother. 2021;doi: 10.1093/jac/dkab345.
Willems, R. P. J., van Dijk, K., Dierikx, C. M., Twisk, J. W. R., van der Klis, F. R. M., de Greeff, S. C., & Vandenbroucke-Grauls, C. M. J. E. (2021). Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study. The Journal of antimicrobial chemotherapy, . https://doi.org/10.1093/jac/dkab345
Willems, Roel P J, et al. "Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study." The Journal of antimicrobial chemotherapy vol. (2021). doi: https://doi.org/10.1093/jac/dkab345
Willems RPJ, van Dijk K, Dierikx CM, Twisk JWR, van der Klis FRM, de Greeff SC, Vandenbroucke-Grauls CMJE. Gastric acid suppression, lifestyle factors and intestinal carriage of ESBL and carbapenemase-producing Enterobacterales: a nationwide population-based study. J Antimicrob Chemother. 2021 Sep 22; doi: 10.1093/jac/dkab345. Epub 2021 Sep 22. PMID: 34550358.
Copy Download .nbib Format: NLM
Esophageal microbiota composition and outcome of esophageal cancer treatment: a systematic review.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus

Plat VD, van Rossen TM, Daams F, de Boer NK, de Meij TGJ, Budding AE, Vandenbroucke-Grauls CMJE, van der Peet DL.
PMID: 34761269
Dis Esophagus. 2021 Nov 11; doi: 10.1093/dote/doab076. Epub 2021 Nov 11.

BACKGROUND: The role of esophageal microbiota in esophageal cancer treatment is gaining renewed interest, largely driven by novel DNA-based microbiota analysis techniques. The aim of this systematic review is to provide an overview of current literature on the possible...

Cite
Plat VD, van Rossen TM, Daams F, et al. Esophageal microbiota composition and outcome of esophageal cancer treatment: a systematic review. Dis Esophagus. 2021;doi: 10.1093/dote/doab076.
Plat, V. D., van Rossen, T. M., Daams, F., de Boer, N. K., de Meij, T. G. J., Budding, A. E., Vandenbroucke-Grauls, C. M. J. E., & van der Peet, D. L. (2021). Esophageal microbiota composition and outcome of esophageal cancer treatment: a systematic review. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus, . https://doi.org/10.1093/dote/doab076
Plat, Victor D, et al. "Esophageal microbiota composition and outcome of esophageal cancer treatment: a systematic review." Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus vol. (2021). doi: https://doi.org/10.1093/dote/doab076
Plat VD, van Rossen TM, Daams F, de Boer NK, de Meij TGJ, Budding AE, Vandenbroucke-Grauls CMJE, van der Peet DL. Esophageal microbiota composition and outcome of esophageal cancer treatment: a systematic review. Dis Esophagus. 2021 Nov 11; doi: 10.1093/dote/doab076. Epub 2021 Nov 11. PMID: 34761269.
Copy Download .nbib Format: NLM
Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study.

Antimicrobial resistance and infection control

Abdallah HM, Alnaiemi N, Reuland EA, Wintermans BB, Koek A, Abdelwahab AM, Samy A, Abdelsalam KW, Vandenbroucke-Grauls CMJE.
PMID: 28630686
Antimicrob Resist Infect Control. 2017 Jun 13;6:62. doi: 10.1186/s13756-017-0219-7. eCollection 2017.

OBJECTIVES: The aim of this study was to determine the prevalence of extended-spectrum β-lactamase (ESBL) and carbapenemase production among Enterobacteriaceae isolated from ambulatory patients with gastrointestinal complaints admitted to El-Ahrar General Hospital, Zagazig, Egypt in the period between January...

Cite
Abdallah HM, Alnaiemi N, Reuland EA, et al. Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study. Antimicrob Resist Infect Control. 2017;6:62doi: 10.1186/s13756-017-0219-7.
Abdallah, H. M., Alnaiemi, N., Reuland, E. A., Wintermans, B. B., Koek, A., Abdelwahab, A. M., Samy, A., Abdelsalam, K. W., & Vandenbroucke-Grauls, C. M. J. E. (2017). Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study. Antimicrobial resistance and infection control, 662. https://doi.org/10.1186/s13756-017-0219-7
Abdallah, H M, et al. "Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study." Antimicrobial resistance and infection control vol. 6 (2017): 62. doi: https://doi.org/10.1186/s13756-017-0219-7
Abdallah HM, Alnaiemi N, Reuland EA, Wintermans BB, Koek A, Abdelwahab AM, Samy A, Abdelsalam KW, Vandenbroucke-Grauls CMJE. Fecal carriage of extended-spectrum β-lactamase- and carbapenemase-producing Enterobacteriaceae in Egyptian patients with community-onset gastrointestinal complaints: a hospital -based cross-sectional study. Antimicrob Resist Infect Control. 2017 Jun 13;6:62. doi: 10.1186/s13756-017-0219-7. eCollection 2017. PMID: 28630686; PMCID: PMC5470242.
Copy Download .nbib Format: NLM
Correction: TreeSeq, a Fast and Intuitive Tool for Analysis of Whole Genome and Metagenomic Sequence Data.

PloS one

Wintermans BB, Brandt BW, Vandenbroucke-Grauls CM, Budding AE.
PMID: 26098360
PLoS One. 2015 Jun 22;10(6):e0131379. doi: 10.1371/journal.pone.0131379. eCollection 2015.

No abstract available.

Cite
Wintermans BB, Brandt BW, Vandenbroucke-Grauls CM, et al. Correction: TreeSeq, a Fast and Intuitive Tool for Analysis of Whole Genome and Metagenomic Sequence Data. PLoS One. 2015;10(6):e0131379doi: 10.1371/journal.pone.0131379.
Wintermans, B. B., Brandt, B. W., Vandenbroucke-Grauls, C. M., & Budding, A. E. (2015). Correction: TreeSeq, a Fast and Intuitive Tool for Analysis of Whole Genome and Metagenomic Sequence Data. PloS one, 10(6), e0131379. https://doi.org/10.1371/journal.pone.0131379
Wintermans, Bastiaan B, et al. "Correction: TreeSeq, a Fast and Intuitive Tool for Analysis of Whole Genome and Metagenomic Sequence Data." PloS one vol. 10,6 (2015): e0131379. doi: https://doi.org/10.1371/journal.pone.0131379
Wintermans BB, Brandt BW, Vandenbroucke-Grauls CM, Budding AE. Correction: TreeSeq, a Fast and Intuitive Tool for Analysis of Whole Genome and Metagenomic Sequence Data. PLoS One. 2015 Jun 22;10(6):e0131379. doi: 10.1371/journal.pone.0131379. eCollection 2015. PMID: 26098360; PMCID: PMC4476833.
Copy Download .nbib Format: NLM
Development of trigger-based semi-automated surveillance of ventilator-associated pneumonia and central line-associated bloodstream infections in a Dutch intensive care.

Annals of intensive care

Kaiser AM, de Jong E, Evelein-Brugman SF, Peppink JM, Vandenbroucke-Grauls CM, Girbes AR.
PMID: 25646148
Ann Intensive Care. 2014 Dec 21;4:40. doi: 10.1186/s13613-014-0040-x. eCollection 2014.

BACKGROUND: Availability of a patient data management system (PDMS) has created the opportunity to develop trigger-based electronic surveillance systems (ESSs). The aim was to evaluate a semi-automated trigger-based ESS for the detection of ventilator-associated pneumonia (VAP) and central line-associated...

Cite
Kaiser AM, de Jong E, Evelein-Brugman SF, et al. Development of trigger-based semi-automated surveillance of ventilator-associated pneumonia and central line-associated bloodstream infections in a Dutch intensive care. Ann Intensive Care. 2014;4:40doi: 10.1186/s13613-014-0040-x.
Kaiser, A. M., de Jong, E., Evelein-Brugman, S. F., Peppink, J. M., Vandenbroucke-Grauls, C. M., & Girbes, A. R. (2014). Development of trigger-based semi-automated surveillance of ventilator-associated pneumonia and central line-associated bloodstream infections in a Dutch intensive care. Annals of intensive care, 440. https://doi.org/10.1186/s13613-014-0040-x
Kaiser, Anna Maria, et al. "Development of trigger-based semi-automated surveillance of ventilator-associated pneumonia and central line-associated bloodstream infections in a Dutch intensive care." Annals of intensive care vol. 4 (2014): 40. doi: https://doi.org/10.1186/s13613-014-0040-x
Kaiser AM, de Jong E, Evelein-Brugman SF, Peppink JM, Vandenbroucke-Grauls CM, Girbes AR. Development of trigger-based semi-automated surveillance of ventilator-associated pneumonia and central line-associated bloodstream infections in a Dutch intensive care. Ann Intensive Care. 2014 Dec 21;4:40. doi: 10.1186/s13613-014-0040-x. eCollection 2014. PMID: 25646148; PMCID: PMC4303743.
Copy Download .nbib Format: NLM
Does death from Covid-19 arise from a multi-step process?.

European journal of epidemiology

Pearce N, Moirano G, Maule M, Kogevinas M, Rodo X, Lawlor DA, Vandenbroucke J, Vandenbroucke-Grauls C, Polack FP, Custovic A.
PMID: 33459897
Eur J Epidemiol. 2021 Jan;36(1):1-9. doi: 10.1007/s10654-020-00711-7. Epub 2021 Jan 18.

The Covid-19 death rate increases exponentially with age, and the main risk factors are having underlying conditions such as hypertension, diabetes, cardiovascular disease, severe chronic respiratory disease and cancer. These characteristics are consistent with the multi-step model of disease....

Cite
Pearce N, Moirano G, Maule M, et al. Does death from Covid-19 arise from a multi-step process?. Eur J Epidemiol. 2021;36(1):1-9doi: 10.1007/s10654-020-00711-7.
Pearce, N., Moirano, G., Maule, M., Kogevinas, M., Rodo, X., Lawlor, D. A., Vandenbroucke, J., Vandenbroucke-Grauls, C., Polack, F. P., & Custovic, A. (2021). Does death from Covid-19 arise from a multi-step process?. European journal of epidemiology, 36(1), 1-9. https://doi.org/10.1007/s10654-020-00711-7
Pearce, Neil, et al. "Does death from Covid-19 arise from a multi-step process?." European journal of epidemiology vol. 36,1 (2021): 1-9. doi: https://doi.org/10.1007/s10654-020-00711-7
Pearce N, Moirano G, Maule M, Kogevinas M, Rodo X, Lawlor DA, Vandenbroucke J, Vandenbroucke-Grauls C, Polack FP, Custovic A. Does death from Covid-19 arise from a multi-step process?. Eur J Epidemiol. 2021 Jan;36(1):1-9. doi: 10.1007/s10654-020-00711-7. Epub 2021 Jan 18. PMID: 33459897; PMCID: PMC7812338.
Copy Download .nbib Format: NLM
The evolving usefulness of the test-negative design in studying risk factors for COVID-19.

Epidemiology (Cambridge, Mass.)

Vandenbroucke JP, Brickley EB, Vandenbroucke-Grauls CMJE, Pearce N.
PMID: 34799477
Epidemiology. 2021 Nov 01; doi: 10.1097/EDE.0000000000001438. Epub 2021 Nov 01.

No abstract available.

Cite
Vandenbroucke JP, Brickley EB, Vandenbroucke-Grauls CMJE, et al. The evolving usefulness of the test-negative design in studying risk factors for COVID-19. Epidemiology. 2021;doi: 10.1097/EDE.0000000000001438.
Vandenbroucke, J. P., Brickley, E. B., Vandenbroucke-Grauls, C. M. J. E., & Pearce, N. (2021). The evolving usefulness of the test-negative design in studying risk factors for COVID-19. Epidemiology (Cambridge, Mass.), . https://doi.org/10.1097/EDE.0000000000001438
Vandenbroucke, Jan P, et al. "The evolving usefulness of the test-negative design in studying risk factors for COVID-19." Epidemiology (Cambridge, Mass.) vol. (2021). doi: https://doi.org/10.1097/EDE.0000000000001438
Vandenbroucke JP, Brickley EB, Vandenbroucke-Grauls CMJE, Pearce N. The evolving usefulness of the test-negative design in studying risk factors for COVID-19. Epidemiology. 2021 Nov 01; doi: 10.1097/EDE.0000000000001438. Epub 2021 Nov 01. PMID: 34799477.
Copy Download .nbib Format: NLM
Surveillance in infection control: are we making progress?.

Current opinion in infectious diseases

Vandenbroucke-Grauls C, Schultsz C.
PMID: 12130939
Curr Opin Infect Dis. 2002 Aug;15(4):415-9. doi: 10.1097/00001432-200208000-00010.

PURPOSE OF THE REVIEW: Surveillance of nosocomial infections is an indispensable tool in infection control, and is used for detecting problem areas, defining patients who are at risk and evaluating intervention strategies. Surveillance techniques are continuously being evaluated and...

Cite
Vandenbroucke-Grauls C, Schultsz C. Surveillance in infection control: are we making progress?. Curr Opin Infect Dis. 2002;15(4):415-9doi: 10.1097/00001432-200208000-00010.
Vandenbroucke-Grauls, C., & Schultsz, C. (2002). Surveillance in infection control: are we making progress?. Current opinion in infectious diseases, 15(4), 415-9. https://doi.org/10.1097/00001432-200208000-00010
Vandenbroucke-Grauls, Christina, and Schultsz, Constance. "Surveillance in infection control: are we making progress?." Current opinion in infectious diseases vol. 15,4 (2002): 415-9. doi: https://doi.org/10.1097/00001432-200208000-00010
Vandenbroucke-Grauls C, Schultsz C. Surveillance in infection control: are we making progress?. Curr Opin Infect Dis. 2002 Aug;15(4):415-9. doi: 10.1097/00001432-200208000-00010. PMID: 12130939.
Copy Download .nbib Format: NLM
Antimicrobial resistance in the Netherlands: a natural experiment?.

Frontiers in public health

Vandenbroucke-Grauls CM.
PMID: 24479116
Front Public Health. 2014 Jan 24;2:5. doi: 10.3389/fpubh.2014.00005. eCollection 2014.

No abstract available.

Cite
Vandenbroucke-Grauls CM. Antimicrobial resistance in the Netherlands: a natural experiment?. Front Public Health. 2014;2:5doi: 10.3389/fpubh.2014.00005.
Vandenbroucke-Grauls, C. M. (2014). Antimicrobial resistance in the Netherlands: a natural experiment?. Frontiers in public health, 25. https://doi.org/10.3389/fpubh.2014.00005
Vandenbroucke-Grauls, Christina Maria Joseph Elisabeth. "Antimicrobial resistance in the Netherlands: a natural experiment?." Frontiers in public health vol. 2 (2014): 5. doi: https://doi.org/10.3389/fpubh.2014.00005
Vandenbroucke-Grauls CM. Antimicrobial resistance in the Netherlands: a natural experiment?. Front Public Health. 2014 Jan 24;2:5. doi: 10.3389/fpubh.2014.00005. eCollection 2014. PMID: 24479116; PMCID: PMC3900872.
Copy Download .nbib Format: NLM
Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit.

Antimicrobial resistance and infection control

Halaby T, Al Naiemi N, Beishuizen B, Verkooijen R, Ferreira JA, Klont R, Vandenbroucke-Grauls C.
PMID: 29177048
Antimicrob Resist Infect Control. 2017 Nov 15;6:117. doi: 10.1186/s13756-017-0275-z. eCollection 2017.

BACKGROUND: Cross-transmission of nosocomial pathogens occurs frequently in intensive care units (ICU). The aim of this study was to investigate whether the introduction of a single room policy resulted in a decrease in transmission of multidrug-resistant (MDR) bacteria in...

Cite
Halaby T, Al Naiemi N, Beishuizen B, et al. Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit. Antimicrob Resist Infect Control. 2017;6:117doi: 10.1186/s13756-017-0275-z.
Halaby, T., Al Naiemi, N., Beishuizen, B., Verkooijen, R., Ferreira, J. A., Klont, R., & Vandenbroucke-Grauls, C. (2017). Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit. Antimicrobial resistance and infection control, 6117. https://doi.org/10.1186/s13756-017-0275-z
Halaby, Teysir, et al. "Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit." Antimicrobial resistance and infection control vol. 6 (2017): 117. doi: https://doi.org/10.1186/s13756-017-0275-z
Halaby T, Al Naiemi N, Beishuizen B, Verkooijen R, Ferreira JA, Klont R, Vandenbroucke-Grauls C. Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit. Antimicrob Resist Infect Control. 2017 Nov 15;6:117. doi: 10.1186/s13756-017-0275-z. eCollection 2017. PMID: 29177048; PMCID: PMC5688743.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 21 entries